OKYO Pharma to present Phase 2 dry eye disease trial data at TFOS conference
OKYO Pharma(OKYO) Proactiveinvestors NA·2024-10-30 21:38
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...